MICHAEL ENWERE: Open Payments
NPI 1417548652 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$276 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $276
Food & beverage: $276
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Janssen Pharmaceuticals, Inc | 1 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, REXULTI, HETLIOZ.
Industry payments across NJ — which companies pay providers there.
